We conducted a randomized, controlled clinical trial to investigate the efficacy of treatment of persistent middle ear effusion (MEE ) and associated hearing loss with a modified Politzer device used in the home setting over a 7-week perio d. Effi cacy was determined by comparing preand posttherapy air-conduction thresholds, tympanometric peak pressures, and otoscop ic find ings. The study group was made up of94 children (1 74 ears), aged 4 to 11 years, who had at least a 2-month history of MEE and assoc iated hearing loss.At study send,patients in the treatment group expe rienced statistically sign ificant improvements in all measured outcomes; no significant improvements were seen in the control group in all measured outcomes. At study 's end, the hearing sensitivity of73 .9% ofthe treated ears was within normal limits, compared with only 26. 7% ofthe control ears. Thesefindings demonstrate that home treatm ent ofchildren with persistent MEE and associated hearing loss with the modified Politzer device is highly efficacious.
Introduction
Methods of ma naging middle ear effusion (MEE) have included (1) periodic obser vation during effo rts to reduce environmental risk factors, (2) decongestant s, (3) anti-histamines, (4) corticosteroid therapy, (5) antimi crobial agents, (6) myringotomy with or without placement of tymp ano stomy tube s, (7) adenoidectomy with or without ton sillectomy, either alone or in combination with myringotomy with or without placement oftympano stomy tube s, and (8) insufflation of the eustachian tube/middle ear system by the Valsalva maneuver or the Politzer meth od.
The efficacy of treatment with drugs or surgery has been questioned. For example, Cantekin et al concluded that decongestant and antihistamine treatment was not benefici al in the man agement ofMEE. l In a meta-analysis of33 studies, Willi ams et al concluded that the benefici al effect of antimicrobial treatment is minor and only short-term. ' Ifmedic ation fails , most otolaryngologists resort to surgical placement of tymp anostomy tube s. 3 One survey showed that 40 % of oto laryngologists believe that tubes are used too frequently.v' There are several arguments again st the surgical treatment of MEE with tympanostomy tubes:
• MEE resol ves spontaneously in 80 to 90% of children within 3 months.s?
• A significantly negative tymp anometric peak pressure (TPP) may per sist after surgical treatment with tympanostomy tubes. "
• Ventilation tube s frequently fall out prematurely, often in 4 to 7 mo nths .":" In such cases, 40 % of patients experience a recurrence ofMEE,3and 33 to 75 % undergo repea t surgery to repl ace them . 10.11 • The risk of one or more episode s of otorrhea following tube plac ement is three times higher than the risk following simple myringotomy.
• Pat ent tube s allow bacteri a, virus es, and allergens to migrate into the middle ear cavit y. 12 • Other reported compli cation s of tympanostomy tube plac ement include (1) tymp anic membrane retraction, (2) postsurgical infection, (3) localized foreign-body reaction, (4) granulatio n, (5) hyalinization , (6) tympanosclerosis, (7) temporary or permanent hearing impairment of varying 567 degrees, (8) persistent tympanic membrane perforation, (9) dislocation of the tube into the middle ear cavity, (10) tube blockage, and (I I) cholesteatoma.v'<"
A clinical practice guideline published in 2004 advises that antibiotics and decongestants are ineffective medical approaches to the treatment of MEE.7 Likewise, antimicrobials , with or without corticosteroids, are not recommended for the routine treatment ofMEE because they do not provide long-term benefits, although they may confer some short-term benefits. This guideline recommends that children who have MEE that has persisted for 4 months or longer and who have persistent hearing loss or other signs and symptoms should be considered for surgical insertion of tympanostomy tubes.
Insufflation of the eustachian tube/middle ear system involves forcing air under pressure through the eustachian tube (retrograde approach) and into the middle ear. The assumption underlying this approach is that frequent repetition of this procedure over a short period of time (on the order of days) can result in the normalization of negative middle ear pressure and the elimination of MEE. The two most common methods of insufflation are the Valsalva maneuver and the Politzer method. The Valsalva maneuver involves performing forced nasal expiration with the nose and lips closed. The Politzer method involves inserting the tip of a rubber air bulb into a patient's nostril, simultaneously compressing the other nostril with a finger, and having the patient swallow as the rubber bulb is compressed. valsalvamaneuver: Cantekin etal evaluated the Valsalva maneuver in 66 children between 2 and 6 years of age who had recurrent or chronic otitis media and functioning tympanostomy tubes. IS None of these children was able to open the eustachian tube with the Valsalva maneuver. The failure of the Valsalva maneuver was attributed to excessive tubal compliance in this age group.
One modification of the Valsalva maneuver involves inserting a balloon into one nostril while compressing the other nostril. 16 When the maneuver is successful, the balloon is inflated. Blanshard et al evaluated the balloon modification of the Valsalva maneuver in 85 children, aged 3 to 10 years, who had bilateral MEE and who were candidates for surgical placement oftympanostomy tubes .17 Approximately one-halfof these children were treated with autoinflation (experimental group), and the remainder were assigned to a control group. Patients in the experimental group achieved a beneficial effect after 2 to 4 weeks of autoinflation. The disadvantages of autoinflation in this study included difficulty in performing the procedure, as 43% of the experimental group performed it irregularly and 12% were unable to perform it at all.
Because of its limitations, the Valsalva maneuver does 568 not hold promise as a treatment for otitis media with effusion and related conditions. Politzer method. The Politzer method (politzerization) was patterned after an inflation technique described by Shea. IS Schwartz et al modified the Politzer method by forcing air through the nostril with a l-oz infant nasal syringe equipped with a plastic tip that was inserted into a nostril. 19 In a controlled study, they measured the effectiveness of politzerization by performing tympanometry 5 and 10 minutes after politzerization in 24 adults and children with MEE and associated tympanic membrane retraction. In the active-treatment group, the mean shift in TPP following politzerization was -9 mm Hp.
An important advantage that the Politzer method has over the Valsalva maneuver is that the forced air is initiated by an external source. The limitations of the Politzer apparatus and modifications thereof include (1) their cumbersome design, (2) a failure to produce continuous and nonfluctuant air-pressure flow, (3) a failure to coordinate the air-pressure stream with swallows, and (4) an absence of air-pressure and air-flow volume controls, which might lead to the generation of either harmful or ineffective air pressures into the middle ear via the nose. Politzerization has generally not been well accepted by patients, and it traditionally has not been suitable for use in the home setting. These limitations are attributable to the design of the currently existing Politzer devices rather than to any facet of the method itself.
An optimum insufflation device would (I) be portable, (2) be operable by a patient or parent, (3) allow for coordination of the air-pressure stream with swallows, and (4) be equipped with air-pressure and air-volume flow controls so that air pressures introduced into the middle ear through the nose are sufficient yet not harmful.P-"
We designed a modified Politzer autoinsufflation device that overcomes the aforementioned limitations of extant devices (figure 1).20.21 Our handheld, battery-operated device emits controlled air pressure and flow that can be adjusted according to the patient's age and magnitude of hearing loss.20. 21 We conducted two earlier studies of treatment with a device very similar to this and found that approximately 75% of patients with MEE and associated hearing loss recovered following treatment.P:" However, a major limitation of these studies was that patients were required to come to a physician's office for treatment 2 or 3 times a week over a period of 6 to 7 weeks. This routine placed a burden on patients in terms of convenience and direct and indirect costs.
In an attempt to obviate the disadvantages of officebased politzerization, we conducted a National Institutes of Health-supported, randomized, controlled study of the feasibility of using our modified Politzer device to treat persistent MEE and associated hearing loss in the home Figure 1 . A: Photograph shows the external appea rance ofour modified Politzer device. B: Schemati c depicts the inner components of the appa ratus used in this study. The "ac tivation means " (12) includes a power source (18) , switch (20) , and a "po wer variation means " (22) . The comp ressor (14) is activated by the activation mean s. The compressor 's components include a motor (24) that turns a motor shaf t (26). The shaf t is connected to a piston (28) by a rotating disk (32) , pin (34), pivoting linkage (30) , and arm Patients and methods Instrumentation. Our modified Politzer device was very similar to the one that we used in our previous two studies. 20 • 21 The federal Food and Drug Admini stration has classified our modified apparatus as a 51O(k) prescripti ve medical device . The device emit s a controlled air pressure and volume velocity sufficient to effect improvement (based on the results of our feasibilit y study) without discomfort. The device has two settings. Settin g I delivers an air pressure of 5.2 psi at a volume velocity of 1,524 mllmin ; settin g 2 deliver s an air pressure of 2.5 psi at a volume velocity of 1,690 mllmin (figure 2).
Patients. More than 600 children were referred to the Cente r for Auditory Research at Brookl yn (N.Y.) Colle ge for possible inclu sion in the study. Suit able candidates were those who had furnished informed consent and who satisfied six study criteria: ( I) age 4 to 11 years, (2) at least a 2-month history of MEE and associat ed hearing loss as documented by a physic ian, (3) pure-tone air-conduction thresholds of 20 dB HL or more at 3 frequencies between 500 and 4,000 Hz with air-bone gaps of 15 dB or more at these frequencies or pure -tone air-conduction thresholds of 25 dB HL or more at 2 frequencies between 500 and 4,000 Hz with air-bone gaps of 15 dB or more at these frequencies at the final pretest, (4) a TPP of -1 00 daPa or less at the final prete st, (5) an otologic diagnosi s ofMEE at the final pretest , and (6) an absenc e of enlarged adenoids, acute otitis media, and other ear abnormalities at the final pretest otologic examination.
Procedures. Treatment was initiated on the day of the final pretest. Each patient's parent administered the treatment twice daily-in the morning before breakfast and in the evening after supper-alternating nost rils with each treatment. During each treatment , the patient was instructed to be in a sitting position . To deliver therapy, the parent inserted a pediatric probe tip (coupled to the device) into one nostril while compressing the other nostril with a finger. Each participant had his or her own device. The parent was given alcohol -soaked wipe s and instructed to clean the tip before each use. The child then held a small amount of water in the mouth without swallowing it. The parent then turned on the device , thereb y introducing air flow into the nostril at a constant volume velocity. After 1 or 2 seco nds of air flow, the parent asked the child to swallow the water.
Parents were provided with a daily log to foster and track compliance. Most patie nts were seen in the office for monitoring at least once near the midpoint of the treatment period, which lasted 7 weeks.
Initially, the air pressure was set to 5.2 psi. As the study progressed, a small proportion of the children (-3 to 4%) in the experimental group, particu larly those whose hearing had been improving markedly, began to experience a slight discomfort during sensations of ear popping at this setting; none had experienced any discomfort at this setting at the beginning of the study. The discomfort appeared to reflect a decrease in the fluid level of the middle ear. In response, we modified the device to incorporate a second airpressure setting of 2.5 psi. Lowering the psi from 5.2 to 2.5 resolved the discomfort. This circumstance forced us to modify our protocol so that the device was set at 2.5 psi for younger children ('5.7 yr) during the first week and increased to 5.2 psi (if tolerated) for the remainder of the study. For older children (>7 yr), the device was set to 5.2 psi thro ugho ut the study. In both of these age groups, the setting was lowered to 2.5 psi if any participant experienced discomfort.
Audiometry was performed by audiologists certified by theAmerican Speech-Lang uage-Hearing Association and licensed by New York State . Otologic eval uations were performed by board-certified otolaryngologists with at least 15 years of exper ience . Audiologic evaluations (air-and bone-conduction threshold testing and tympanometry) and otolaryngologic evaluations (otoscopy) were performed upon enrollment in the study and 4 weeks after the completion of the treatment (i.e ., 11wk following study entry) . However, parents were advised to discontinue treatment if a child developed a cold or upper respira tory infection and to complete the treatment after the cold or upper respiratory infection resolved. As a result, a small number of children were seen later than 11 weeks after study entry. 572 The patients in the control group did not undergo sham treatment with a dummy device because their parents would have immed iately recog nized it as such.These parents were instructed to contact the investigators immediately if they noticed any worsening of hearing status.
Audio logists were blinded to each patient's otologic findings, and otolaryngologis ts were blinded to each patient's audiometric findings . At the posttest, audiologists and otolaryngologists were blinded to each patient's disease status . The statistician was blinded as to whether test results were obta ined before or after therapy and to the disease status of each patient.
Sample size determination was made using power formulae for Student's t tests ." To achieve a power of 90% or more for each of our hypotheses, the sample size to be recruited was 110 (55 for each group, a number calculated to include a possible 10% attrition rate). An alpha level of 0.05 was used for all statistical tests. For statistical analysis, an absent TPP was coded as -450 daPa.
ENT
All patients in the control group who had not spon taneously recovered by the posttest were given the option of receiving treatment with the study device upon the conclusion of their involvement in the study. The outcomes of these controls will be presented in another report.
Results
A total of 94 children (174 ears), aged 4 to II years, met the inclusion criteria and were entered into the study. Of this group, 47 patients (88 ears) were randomly assigned to the experimental group and 47 patients (86 ears) were assigned to the control group.
Comp liance. Complete compliance with the treatment protocol was demons trated by 46 of the 47 experimental patients (97.9%), based on inspection of their dai ly logs and our assessme nt of their familiarity with the device; in the remaining patient, compliance was judged to be moderate. Our device appeared to be easy to use at home and was well tolerated by patients and parents.
A ir-conduction thresholds and TPPs. For each ear, the mean pretest air-conduction thresho lds for the experimental and control groups were similar-that is, within 3.0 dB at 500 Hz, 5. 1dB at 1,000 Hz, 4.2 dB at 2,000 Hz, and 1.4 dB at 4,000 Hz (table I) . At the pretest, the mean 4-frequency pure-tone average (PTA) in the experimental group was 29.6 in the right ear and 32.6 dB HL in the left ear; in the control group, the mean for both ears was 29.3 dB HL. Overa ll, the mean PTAs in both ears in both groups were symmetrical to within 3.3 dB.
The mean pretest TPPs in both ears in both groups were symme trical to within 40.3 daPa (table I) .All posttest mean air-conduction thresholds in the experimental group were less than 20 dB HL. By contrast, in the control group, all but I posttest mean air-conduction thresho ld were higher than 20 dB HL. The exception was seen at 2,000 Hz in the left ear, where themean thresho ld was 17.6 dB HL; in the right ear at that frequency, the mean (20.7) was only slightly higher than 20 dB HL.
Comparisons of the pre-and posttest measures for each ear in each group were obtained using paired Student's t tests. In the experimental group, these comparisons revealed statistically significant improvements (p < 0.001) in mean air-conduction thresholds across the entire frequency range in both ears (table 2). No statistically significant improvements in mean air-conduction thresholds occurred at any frequency or in either ear in the control group (p > 0.05).
Likewise, the experimental group experienced statistically significant improvements (p < 0.001) in mean TPPs in both ears, while no such improvements were seen in the control group (p > 0.05).
Comparisons of the differences in scores (posttest minus pretest) for each ear between the two groups were obtained using independent sample Student's t tests (as- suming equal variances). These comparisons revea led statistically significant differences (p < 0.00 I) between the two groups in the difference scores throughout all frequencies in both ears, indicating that all mea n improvements in air-conduction thresholds from pre-to posttest in the experimental group were significantly greater than those for the contro l group (table 3) . Simil arly, the mean posttest improvement in TPP in the right ear in the experimental group was significantly greater (p < 0.03 ) than that in the right ear in the control group. In the left ear, the contras t was even more striking (p < 0.00 I), as the results reflected not merely an improvement in mean TPP in the left ear in the experimental group, but an actual deterioration in mean TPP in the left ear in the control gro up. Although the observed difference in change in the mean TPP s from pre-to posttest between the two groups was greater in the left ear (181.1 daPa) than the right ear (75.5 daPa), there is no reaso n to concl ude that the true effec t is different for the two ears . However, these values are only point estimates of the differences in mean change scores, and the confidence interva ls over lap substantially. The refore, the appare nt discrepancy between the results in the right and left ears is not statistically significant.
Hearingsensitivity.Overall, hearing sensitivity returned to with in normal limit s in at least one ear in 40 of the 47 patients (85. 1%) in the experim ental gro up, compared with only IS of the 47 patient s (31.9 %) in the control group (table 4) . In term s of the number of ears, recovery was see n in 65 of 88 experimental ears (73 .9%) and 23 of 86 control ears (26 .7%). At the pretest, bilateral hearing loss was prese nt in 4 1 experi mental patient s; at the postte st, hearing had been Table 3 
. Means (confidence intervals) and significance levels (P) for the difference between groups (experimental minus control) in the difference (posttest minus pretest) in air-conduction thresholds (dB HL) and TPPs (daPa)

Ear
Surgery Exam Chairs & Tables
Rugged all metal construction and industry leading lowvoltage technology throughout the complete line of power exam chairs and power surgery tables make them ultra quiet. provide more power. and are more reliable and safer than traditional highvoltage competitive models, Five models of treatment cabinets in laminate and stainless steel construction. in standard and "slim line" designs, are also available in special configurations. Coupled with MTl's cabinets. many different stools and sixteen models of power/manual exam chairs and surgery tables help "ollrjal11ily". assist "yollrjal11ily" to deliver the highest quality otolaryngology care possible. Otoscopic fi ndings . We examined the relationship between hearing sensitivity in the 65 experimental ears that had achieved norm al hearing at the posttest and findings on pneumatic oto scop y. Norm al tympanic membrane mobilit y was seen in 49 of these ears (75.4%), mode rate mobilit y in 12 ( 18.5%), and no mobil ity in 4 (6.2%). Thu s, either normal or mode rate mobil ity was observed in 61 of the 65 ears (93.8%). Th is finding further substantiates the ef ficacy of our device for improving middle ear function and hearing sensitivity in children with MEE. The absenc e of tymp anic membrane mobilit y in 4 normal ears sugges ts that an immobi le eard rum is not necessarily associated with hearing loss.
Follow-up. Upon completion of participation in the study, all parents were advised to notify us if they or others noticed any chan ge in hearin g status. The parents of 6 children who had improved following act ive treatment did contact us. One child developed MEE and hearing loss after 3 months; his hearing sensitivity was restored to Co ntro l group 3/8 (37.5) 3/8 (37.5) within normal limit s by an additional 2 wee ks oftreatmen t. Another parent called after 7 months, and we found that the child had developed recurrent MEE and hearing loss; this child's hea ring also returned after an additional 2 weeks of treatment. Another parent called afte r 9 month s, but her child's hearing sensitivity was found to be normal.
Calls from 3 other parents-2 of which came more than 1year after treatment-indicated that tymp anostom y tubes had been placed in 2 children. One of these children had alre ady received 2 sets of tubes prior to enrollment in our study. Following the study, the child 's hearing sensitivity and otologic status, which had been monitored by an otologist , had remained within normal limits for 1 year.
Sub sequ ent ly, however, the child experienced arecurrence of MEE and associated hearing loss, and a third set of tubes was inserted. Nevertheless, MEE with hearing loss recurred again 3 months later. The pat ient underwent a repeat cour se of home treatm ent with our device, and his hearing began to improve. Two children were diagnosed with enlarged adenoids; 1 underwent an adenoidectomy without tympanostomy tube placement and his hearing return ed to norm al, while the other underwent an aden oidectomy with insertion of tymp anostomy tube s.
We also placed telephone calls to 10 rand oml y selected parent s of children in the experimental group. The se calls were made 12 to 18 months following the completion of the child's participation in the study. All of these parent s reported satisfaction with the outco me of the treatment.
Discussio n
The results of our investigation indicate that twice-dai ly home treatment of persistent MEE and associated hearing impairment over a period of7 weeks with a modified Politzer device that controls air flow and air press ure is highly effic acious in chi ldren aged 4 to II years. All mean posttest air-conduction thresholds and TPPs were markedly better than the mean pretest values in the experimental group but not in the control group; the pre-and posttest differences in the experimental group were statistically significant (p < 0.001 ). Also, the differences between groups in the mean change from pre-to postte st present in all ears in both groups at the pretes t. Hearing sensitivity wasjudged to be within normal 
I
Since 1977, we have been offering the top ENT instruments-the ones that professionals ask for and use most often. We approach our work passionately and we perform it competently. No giant multinational has bought us out . We are an independent business with a human face, for whom the client is first and foremost an individual. , = :----___ La difference that makes the difference! limits if the air-conduction thresholds were less than 20 dB HL at any of 3 frequencies or less than 25 dB HL at either of 2 frequencies.
Althou gh posttest hearing sensiti vity did not improve to within normal limits in either ear in 7 ofthe 47 experimental patients (14.9%), reports by parents , teacher s, and patients themselves indicated that these patients' listening and attention beha viors suggested that some degree of improvement in hearing status had occurred during treatment. It is possible that their hearing sensitivity actually did improv e during treatment only to subsequently deteriorate because of a recurrence of MEE prior to the posttest; the posttest was not perform ed until 4 week s after the completion of treatment. In a pilot study that we conducted prior to this investigation, audiologic evaluations were performed immediately before and after treatment, and we observed immediate improvement in hearing sensitivity in allpatients after each administration. These pilot data support our hypothe sis that the 7 treatment failure s were attributabl e to the lag between the end of treatment and the posttest. The audiologic, otolo gic, and demog raphic characteristics of the 7 exper iment al patients whose hearing was not restored were no different from the data on those whose hearing did recover to within norm al limits. We also considered the possibility that the duration of treatment was insufficient for these 7 patients, and we offered them a 2-to 3-week extension. The results of the exten ded treatment will be reported in a separate article.
In conclusion, the results of our study indicate that the use of our modified, automated Politzer device for the home treatment of MEE in children aged 4 to II years was highly successful. Marked impro vement was reflected by evaluat ions of pure-tone air-conduction thresholds, TPPs , and tympanic membrane mobility at the postte st 4 weeks following the comple tion of treatment. Future research is needed to generaliz e findin gs to children younger than 4 years, to teenagers , and to adults . Further study is also needed to explore long-term outcomes. Still , our anecdotal observations suggest that there is indeed a long-term benefit.
